<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001859453</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001831828</issuerCik>
            <issuerName>VERA THERAPEUTICS INC CL A</issuerName>
            <secFileNumber>001-40407</secFileNumber>
            <issuerAddress>
                <ns2:street1>8000 Marina Boulevard, Suite 120</ns2:street1>
                <ns2:city>Brisbane</ns2:city>
                <ns2:stateOrCountry>CA</ns2:stateOrCountry>
                <ns2:zipCode>94005</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>6507700077</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>MARSHALL FORDYCE</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Director</relationshipToIssuer>
                <relationshipToIssuer>Officer</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>COMMON</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
                <address>
                    <ns2:street1>1 New York Plaza</ns2:street1>
                    <ns2:street2>8th Floor</ns2:street2>
                    <ns2:city>New York</ns2:city>
                    <ns2:stateOrCountry>NY</ns2:stateOrCountry>
                    <ns2:zipCode>10004</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>31250</noOfUnitsSold>
            <aggregateMarketValue>1173437.50</aggregateMarketValue>
            <noOfUnitsOutstanding>54827665</noOfUnitsOutstanding>
            <approxSaleDate>09/11/2024</approxSaleDate>
            <securitiesExchangeName>NASDAQ</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <acquiredDate>09/11/2024</acquiredDate>
            <natureOfAcquisitionTransaction>Exercise of Stock Options</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>31250</amountOfSecuritiesAcquired>
            <paymentDate>09/11/2024</paymentDate>
            <natureOfPayment>Cash</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>10b5-1 Sales for MARSHALL FORDYCE</name>
                <address>
                    <ns2:street1>8000 Marina Boulevard, Suite 120</ns2:street1>
                    <ns2:city>Brisbane</ns2:city>
                    <ns2:stateOrCountry>CA</ns2:stateOrCountry>
                    <ns2:zipCode>94005</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>COMMON</securitiesClassTitle>
            <saleDate>08/28/2024</saleDate>
            <amountOfSecuritiesSold>30320</amountOfSecuritiesSold>
            <grossProceeds>1117141.09</grossProceeds>
        </securitiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>10b5-1 Sales for MARSHALL FORDYCE</name>
                <address>
                    <ns2:street1>8000 Marina Boulevard, Suite 120</ns2:street1>
                    <ns2:city>Brisbane</ns2:city>
                    <ns2:stateOrCountry>CA</ns2:stateOrCountry>
                    <ns2:zipCode>94005</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>COMMON</securitiesClassTitle>
            <saleDate>08/14/2024</saleDate>
            <amountOfSecuritiesSold>15625</amountOfSecuritiesSold>
            <grossProceeds>586926.56</grossProceeds>
        </securitiesSoldInPast3Months>
        <remarks>The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.&#13;
</remarks>
        <noticeSignature>
            <noticeDate>09/11/2024</noticeDate>
            <planAdoptionDates>
                <planAdoptionDate>04/23/2024</planAdoptionDate>
            </planAdoptionDates>
            <signature>/s/ Marshall Fordyce</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 5078}]
144
0001859453
XXXXXXXX
LIVE
0001831828
VERA THERAPEUTICS INC CL A
001-40407
8000 Marina Boulevard, Suite 120
Brisbane
CA
94005
6507700077
MARSHALL FORDYCE
Director
Officer
COMMON
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
31250
1173437.50
54827665
09/11/2024
NASDAQ
Common
09/11/2024
Exercise of Stock Options
Issuer
N
31250
09/11/2024
Cash
N
10b5-1 Sales for MARSHALL FORDYCE
8000 Marina Boulevard, Suite 120
Brisbane
CA
94005
COMMON
08/28/2024
30320
1117141.09
10b5-1 Sales for MARSHALL FORDYCE
8000 Marina Boulevard, Suite 120
Brisbane
CA
94005
COMMON
08/14/2024
15625
586926.56
The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
09/11/2024
04/23/2024
/s/ Marshall Fordyce